Navigation Links
The Quigley Corporation Reports Fourth Quarter and 2008 Annual Results; Continues To Invest In Pharmaceutical R&D Future
Date:2/26/2009

ve months ended December 31, 2008 reflects results from discontinued operations associated with the sale of Darius that included a gain on disposal of $737,000 and income from discontinued operations of $139,000, totaling $876,000 as compared to a loss from discontinued operations of $602,000 for the same period in 2007.

The Company continued to invest in pharmaceutical research and development including QR448(a), a veterinary anti-viral compound against Infectious Bronchitis Virus (IBV) in poultry, and QR-333, an investigational new formulation for treating conditions associated with diabetic peripheral neuropathy.

According to The World Health Organization estimates, more than 171 million people have diabetes worldwide. It is also estimated that 20 million people, representing approximately 7% of the United States population have diabetes of which some 60% will suffer from mild to severe nerve damage due to diabetic peripheral neuropathy. Conditions associated with diabetic peripheral neuropathy include numbness, skin ulcers, constant pain or extreme sensitivity to stimulus.

The research by the Company is part of its strategic initiatives to generate future growth. These initiatives include capitalizing on the growth potential of Quigley Pharma by developing natural-source potential prescription products particularly for diabetic peripheral neuropathy, avian flu in animals, rheumatoid arthritis and for protection against ionizing radiation.

The following is a summary of ethical pharmaceutical activities that occurred during 2008 and 2009 to date:

Ongoing Quigley Pharma research and development initiatives include investing in its key pharmaceutical formulations, QR-333. The last subject in the Phase IIb study has completed treatment at the end November 2008 and the study is now in the final stage of data collection, evaluation and study conclusions. The Company, after c
'/>"/>

SOURCE Quigley Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Quigley Announces Completion of Phase IIb Clinical Study of QR-333 For Diabetic Peripheral Neuropathy on November 25, 2008; Collection and Evaluation of Study Data to Begin Immediately Thereafter
2. The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future
3. The Quigley Corporation Names Gerard M. Gleeson to Succeed Retiring George J. Longo as Chief Financial Officer and Director
4. The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future
5. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007
6. The Quigley Corporation Announces Sale of Its Health and Wellness Segment
7. Service Corporation International Announces Fourth Quarter 2008 Financial Results and Comments on Outlook for 2009
8. Heyltex Corporation to Become Exclusive Distributor of ThyroShield(R)
9. CUREXO Technology Corporation Announces 510(k) Submission to FDA for Total Knee Arthroplasty Application
10. Providence Service Corporation Announces Bylaw Amendments to Improve Corporate Governance
11. Service Corporation International Announces Schedule for Its Fourth Quarter 2008 Earnings Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , ... September 02, 2015 ... ... 2015 Warrior-Family Symposium (WFS), cosponsored by the Military Officers Association of America ... the event, "Our Nation's Military: Caring For Our Own,” expert panelists will ...
(Date:9/2/2015)... Angeles, CA (PRWEB) , ... September 02, 2015 , ... ... to expand their fleet of truly superb luxury vehicles based on which of the ... pleased to announce the latest step forward in pursuit of this goal: a 2015 ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... Blincyto® (blinatumomab) – in the news recently following a decision by the Centers ... patients – is likely to average approximately $71,000 or roughly 40% of its ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... data collection, cloud analytics and workflow solutions today announced the September 2015 ... researchers to participate in interactive programs in which ERT scientists and partner ...
(Date:9/2/2015)... CA (PRWEB) , ... September 02, 2015 , ... ... Internet of Things, announces its latest addition to its screen mirroring and extending ... award-winning Splashtop Extended Wireless Display, which operates in local WIFI setting, the new ...
Breaking Medicine News(10 mins):Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 3Health News:Luxury Line Auto Rental Announces Addition of the Rolls Royce Wraith to their Luxury Fleet 2Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 2Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 3Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 4Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 3Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 3
... over 55 use colonoscopies for early detection of cancer, ... the costs since 2002. This was shown by an ... current edition of Deutsches rzteblatt International (Dtsch ... , The authors evaluated 245 263 colonoscopies performed ...
... of the highest rates, international survey finds , , TUESDAY, ... of the highest lifetime rates of tobacco and alcohol use ... or cocaine at least once in their lives, a new ... alcohol, tobacco and illegal drug use in 17 countries in ...
... following is a,statement by Christine James-Brown, President and CEO, ... the authority and opportunity,to delay the Medicaid Rehabilitative Services ... other controversial rules by including a,moratorium on them in ... a made a loud and clear statement that it ...
... Through ... Commercialization, LOS ANGELES, July 1 ... has appointed Denis A. O,Connor,as Chief Executive Officer of the company ... O,Connor has held senior,management positions at Philips Medical Systems, Sony Medical ...
... the only medical liability insurance company operating in Ohio that is ... will make its first cash distribution to its policyholders. This action ... outstanding loss results for the 2004 and 2005 policy years, closing ... ...
... HOUSTON, July 1 Millar Instruments, Inc. ... and,pressure-volume (P-V) systems and Telemetry Research Ltd, ... physiological signals in,freely moving laboratory animals, today ... Telemetry Research provides wireless measurement of ...
Cached Medicine News:Health News:Drug Use Increasingly Common in All Countries 2Health News:Statement by Christine James-Brown, President and CEO, Child Welfare League of America (CWLA) Re: Moratorium on Medicaid Regulations 2Health News:Medical Tactile, Inc. Announces Appointment of Denis A. O'Connor as CEO & Member of Board of Directors 2Health News: Great Doctors Produce Great Results (Healthcare Underwriters Group Mutual of Ohio Pays A Cash Dividend): -- Healthcare Underwriters Group Mutual of Ohio Pays Its First Cash Distribution to Its Insured Owners 2Health News:Millar Instruments Offers Telemetry Systems Through Worldwide Distribution Agreement with Telemetry Research Ltd 2
(Date:9/2/2015)... , Sept. 2, 2015 Research ... addition of the "An Introduction to Medical ... November 2-3, 2015)" conference to their offering. ... comprehensive introduction to the regulations and requirements that ... be highly interactive, using real life examples and ...
(Date:9/2/2015)... , Sept. 2, 2015  Research and Markets ... the "An Introduction to the Medical Devices ... conference to their offering. This ... medical device legislation. It will explain the Directives ... Notified Bodies, how to choose one and outline ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/6x789c/new_eu ) has ... Legislation (London, UK - November 16-17, 2015)" conference ... EU modules concerning Pharmacovigilance are a major departure in ... Europe . The intention of the course ... examine how they overlap and fit together and what ...
Breaking Medicine Technology:An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2
... Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting ... Wednesday, November 9, 2011 at 11:30 a.m. MT/1:30 p.m. ET/10:30 ... Amylin Pharmaceuticals, will provide a corporate overview. The ... Amylin,s corporate website at www.amylin.com , and a recording ...
... 2011 Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR ) ... Annual CLSA AsiaUSA Forum to be held November 7-9, 2011 ... Officer, is scheduled to present an overview of the Company ... A live webcast and subsequent archived replay of ...
Cached Medicine Technology:Questcor Pharmaceuticals to Present at CLSA's 4th Annual AsiaUSA Forum on November 7, 2011 2
Magnetic Farnsworth D15 kit Magnets move the color disks. Protects disks from fingerprints. Keeps all the disks in one place. Clear glass insures accurate color perception. Makes color testing fun....
... Farnsworth panel D15 test evaluation ... ways to arrange caps with automatic ... analysis, manual color deficiency analysis, calculation ... of age-corrected CCI, eye selection (OD, ...
... a Matching Card, three HRR symbol cards and ... child for subsequent HRR 4th Edition color testing. ... For the youngest patients, the parents can borrow ... concept of matching and become familiar with the ...
Spanish HRR/Amsler combination with Spanish and English directions for both HRR and amsler tests plus occluding glasses....
Medicine Products: